Topical Review: Levetiracetam in Pediatrics
- 1 February 2005
- journal article
- review article
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 20 (2), 87-93
- https://doi.org/10.1177/08830738050200020101
Abstract
Levetiracetam is a new antiepileptic drug whose efficacy and tolerability are already well known in adults. Few studies are available in children. This review, based on the international literature, aims to identify and make known the possible indications for levetiracetam in childhood. Most studies suggest that levetiracetam is effective against partial and generalized epilepsy. In resistant partial epilepsy, the percentage of responders reaches 64%, with 8 to 23% seizure free. Levetiracetam is used to treat symptomatic and idiopathic epilepsies. The drug has also proven effective against photosensitivity and epileptic and nonepileptic myoclonus. The most frequent side effects involve the behavioral sphere and manifest mostly in patients with a history of behavioral problems. In some patients, levetiracetam increases the number of seizures, but this adverse reaction can be partially avoided with slow titration. Doses for children should be 130 to 140% of those advised for adults. Levetiracetam seems to have a broad spectrum of action and is, on the whole, well tolerated. Its efficacy against generalized epilepsy is particularly promising in childhood. ( J Child Neurol 2005;20:87—93).Keywords
This publication has 34 references indexed in Scilit:
- Antiepileptic drugs: coprescription of proconvulsant drugs and oral contraceptives: a national study of antiepileptic drug prescribing practiceJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Pharmacokinetic Study of Levetiracetam in ChildrenEpilepsia, 2001
- Pharmacokinetics of LevetiracetamEpilepsia, 2001
- Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurones of rat hippocampal slicesNeuroscience Letters, 2001
- Levetiracetam does not modulate neuronal voltage-gated Na+and T-type Ca2+currentsSeizure, 2001
- Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsyEuropean Journal of Pharmacology, 1998
- Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placeboJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsyEpilepsy Research, 1995
- Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and ratsEuropean Journal of Pharmacology, 1993
- ucb L059, a novel anti-convulsant drug: pharmacological profile in animaisEuropean Journal of Pharmacology, 1992